Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 28, 2005

Book review

Favourites:
ADD

Review article

Cell-Penetrating Peptides: Mechanisms and Applications
pp. 3597-3611(15)
Authors: El-Andaloussi, S.; Holm, T.; Langel, U.

Favourites:
ADD

Endocytosis and Cationic Cell-Penetrating Peptides - A Merger of Concepts and Methods
pp. 3613-3628(16)
Authors: Fotin-Mleczek, M.; Fischer, R.; Brock, R.

Favourites:
ADD
Favourites:
ADD

Conjugates of Oligonucleotides and Analogues with Cell Penetrating Peptides as Gene Silencing Agents
pp. 3639-3654(16)
Authors: Zatsepin, T. S.; Turner, J. J.; Oretskaya, T. S.; Gait, M. J.

Favourites:
ADD

Vascular Homing Peptides with Cell-Penetrating Properties
pp. 3655-3660(6)
Authors: Ruoslahti, E.; Duza, T.; Zhang, L.

Favourites:
ADD

Calcitonin-Derived Carrier Peptides
pp. 3661-3669(9)
Authors: Neundorf, I.; Beck-Sickinger, A. G.

Favourites:
ADD

Bioplex Technology: Novel Synthetic Gene Delivery Pharmaceutical Based on Peptides Anchored to Nucleic Acids
pp. 3671-3680(10)
Authors: Simonson, O. E.; Svahn, M. G.; Tornquist, E.; Lundin, K. E.; Smith, C. I.E.

Favourites:
ADD
Favourites:
ADD

Hepatotoxicity of Antiretroviral Drugs
pp. 3697-3710(14)
Authors: Abrescia, N.; D'Abbraccio, M.; Figoni, M.; Busto, A.; Maddaloni, A.; Marco, M. D.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content